Adamas Pharmaceuticals Earnings Surprises image   This ADMS earnings surprises page last updated 11/15/2021
Adamas Pharmaceuticals Earnings Surprises Chart
Data adjusted for ADMS split history

PeriodExpectedActualSurprise
Q2 2021 -0.29 -0.27 +0.02 (-7%)
Q1 2021 -0.51 -0.36 +0.15 (-29%)
Q4 2020 -0.51 -0.64 -0.13 (+25%)
Q3 2020 -0.48 -0.42 +0.06 (-12%)
Q2 2020 -0.61 -0.37 +0.24 (-39%)
Q1 2020 -0.79 -0.59 +0.20 (-25%)
Q4 2019 -0.85 -0.83 +0.02 (-2%)
Q3 2019 -0.89 -0.99 -0.10 (+11%)
Q2 2019 -0.98 -0.90 +0.08 (-8%)
Q1 2019 -1.15 -1.08 +0.07 (-6%)
Q4 2018 -1.34 -1.06 +0.28 (-21%)
Q3 2018 -1.34 -1.22 +0.12 (-9%)
Q2 2018 -1.41 -1.26 +0.15 (-11%)
Q1 2018 -1.37 -1.35 +0.02 (-1%)
Q4 2017 -1.18 -1.27 -0.09 (+8%)
Q3 2017 -0.98 -1.04 -0.06 (+6%)
Q2 2017 -0.81 -0.93 -0.12 (+15%)
Q4 2016 -0.80 -0.68 +0.12 (-15%)
Q2 2016 -0.77 -0.78 -0.01 (+1%)
Q1 2016 -0.76 -0.65 +0.11 (-14%)
Q3 2015 -0.82 -0.81 +0.01 (-1%)
Q2 2015 -0.70 -0.78 -0.08 (+11%)
Q1 2015 -0.74 -0.69 +0.05 (-7%)
Q3 2014 -0.44 -0.57 -0.13 (+30%)
Adamas Pharmaceuticals Revenue Surprises Chart
PeriodExpectedActualSurprise
Q2 2021 21.95M 21.97M +22000 (0%)
Q1 2021 20.02M 19.31M -0.71M (-4%)
Q4 2020 20.96M 21.01M +50000 (0%)
Q3 2020 20.95M 20.18M -0.77M (-4%)
Q2 2020 15.32M 18.79M +3.47M (+23%)
Q1 2020 15.36M 14.48M -0.88M (-6%)
Q4 2019 15.81M 16.35M +538000 (+3%)
Q3 2019 14.07M 13.93M -0.14M (-1%)
Q2 2019 12.88M 12.69M -0.19M (-1%)
Q1 2019 12.31M 11.66M -0.65M (-5%)
Q4 2018 13.26M 13.31M +55000 (0%)
Q3 2018 10.17M 10.61M +443000 (+4%)
Q2 2018 4.86M 7.57M +2.71M (+56%)
Q1 2018 1.60M 2.55M +953000 (+59%)
Q4 2017 840000 568000 -0.27M (-32%)
Q3 2017 40000 1000 -39000 (-98%)
Q2 2017 40000 2000 -38000 (-95%)
Q4 2016 190000 37000 -0.15M (-81%)
Q2 2016 230000 222000 -8000 (-3%)
Q1 2016 320000 175000 -0.14M (-45%)
Q3 2015 90000 768000 +678000 (+753%)
Q2 2015 30000 398000 +368000 (+1227%)
Q1 2015 6.78M 226000 -6.55M (+3333233%)
Q3 2014 60000 21.50M +21.44M (-100%)
Quotes delayed 20 minutes

Email EnvelopeFree ADMS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

FreightCar America (RAIL): 11/15/2021 6:00 AM
Clear Secure (YOU): 11/15/2021 6:30 AM
InfuSystems Holdings (INFU): 11/15/2021 6:30 AM
Digimarc (DMRC): 11/15/2021 7:00 AM
1847 Goedeker (GOED): 11/15/2021 7:00 AM
Amplify Energy (AMPY): 11/15/2021 7:00 AM
CareMax (CMAX): 11/15/2021 7:00 AM
Trevena (TRVN): 11/15/2021 7:00 AM
Kala Pharmaceuticals (KALA): 11/15/2021 7:00 AM
Brainstorm Cell (BCLI): 11/15/2021 7:00 AM

More from the Next Earnings Dates Calendar

Earnings History:

Apartment Income REIT (AIRC): 11/14/2021 After close
Air T (AIRT): 11/12/2021 5:00 PM
Willamette Valley (WVVI): 11/12/2021 5:00 PM
Timberland Bancorp (TSBK): 11/12/2021 5:00 PM
Humacyte (HUMA): 11/12/2021 After close
Network-1 Technologies (NTIP): 11/12/2021 After close
Prudential Bancorp (PBIP): 11/12/2021 After close
AECOM (ACM): 11/12/2021 After close
ThermoGenesis Holdings (THMO): 11/12/2021 After close
AgeX Therapeutics (AGE): 11/12/2021 After close

More from the Earnings History archive
Adamas Pharmaceuticals (ADMS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ADPT Past Earnings
ADTX Past Earnings
ADUS Past Earnings
ADVM Past Earnings
ADXS Past Earnings
AEMD Past Earnings
AERI Past Earnings
AFIB Past Earnings
AGEN Past Earnings
AGIO Past Earnings
On this page we presented the ADMS earnings surprises information for Adamas Pharmaceuticals, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on ADMS (or any other given stock) can benefit from researching all of the Adamas Pharmaceuticals past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Adamas Pharmaceuticals earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about ADMS's next earnings report. In your continued research on Adamas Pharmaceuticals we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for ADMS. Thanks for visiting, and the next time you need to research ADMS earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.
 

Adamas Pharmaceuticals Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.